INTRODUCTION
Ki-67 has extensively been studied in lung neuroendocrine tumors (NETs), including typical and atypical carcinoid, yet it has never been formally accepted into classification. Its clinical application was limited to the differential diagnosis toward neuroendocrine carcinomas and the characterization of car...
A. Laffi, Valentina Veronesi, Riccardo Papa et al.· Expert Review of Respiratory...· 0 citations
INTRODUCTION
Lung carcinoids are well-differentiated neuroendocrine tumors (NETs), designated in the current thoracic WHO classification as typical carcinoids (grade 1) and atypical carcinoids (grade 2), whereas rare tumors with carcinoid/NET morphology and >10 mitoses/2mm2 are designated as large cell neuroendocrine c...
N. Rekhtman, Matthew G. Hanna, Paul Hofman et al.· Journal of Thoracic Oncology· 0 citations
Lung neuroendocrine tumours (NETs, also known as carcinoids) are rapidly rising in incidence worldwide but have unknown aetiology and limited therapeutic options beyond surgery. The current WHO classification, based on mitotic count and presence or absence of necrosis, divides lung NETs into grade-1 typical, and grade-...
A. Sexton-Oates, É. Mathian, N. Candeli et al.· Molecular Cancer· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
